2019 tables: Institutions - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

Request a badge Export CSV
# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share* 2017–2018
1 F. Hoffmann-La Roche AG, Switzerland 54.75 57.50 136 -0.9%
2 Novartis International AG, Switzerland 41.58 31.42 109 -28.7%
3 AstraZeneca plc, United Kingdom (UK) 30.13 30.10 136 -5.7%
4 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 16.67 18.04 85 2.2%
5 BASF SE, Germany 8.08 8.75 49 2.1%
6 Sanofi, France 5.17 7.21 33 31.7%
7 Bayer AG, Germany 3.61 5.51 41 43.9%
8 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 6.37 5.49 24 -18.7%
9 UCB S.A., Belgium 4.16 5.32 14 20.8%
10 Thales S.A., France 4.11 4.36 37 0.1%
11 Merck KGaA, Germany 3.92 3.84 24 -7.5%
12 Norwegian Research Centre AS (NORCE), Norway 2.23 3.58 45 51.8%
13 Novo Nordisk A/S, Denmark 5.86 3.33 16 -46.3%
14 Royal Dutch Shell plc (Shell), Netherlands 2.88 3.22 15 5.6%
15 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.95 3.09 17 -1.1%
16 Techint Group, Italy 2.11 2.80 14 25.1%
17 Total S.A., France 2.08 2.70 14 22.7%
18 Sociedad Europea de Análisis Diferencial de Movilidad SL (SEADM), Spain – 2.56 4 N/A
19 Johnson Matthey (JM), United Kingdom (UK) 2.12 2.45 11 9.3%
20 Austrian Centre of Industrial Biotechnology (ACIB), Austria 2.10 2.12 10 -4.6%
21 Haldor Topsøe A/S, Denmark 2.14 2.03 7 -10.4%
22 Metrohm DropSens S.L., Spain 1.00 2.00 2 88.8%
23 ams-OSRAM AG, Austria 0.54 1.94 6 238.3%
24 KWH Water B.V., Netherlands 2.62 1.74 11 -37.2%
25 AIT Austrian Institute of Technology GmbH, Austria 3.43 1.67 20 -54.2%
26 Research Institutes of Sweden (RISE), Sweden 1.83 1.65 16 -14.8%
27 Anglo American plc, United Kingdom (UK) 1.64 1.62 7 -6.7%
28 Oxford Nanopore Technologies Ltd., United Kingdom (UK) 0.25 1.46 4 452.0%
29 Carl Zeiss AG, Germany 0.33 1.43 8 304.1%
30 Surflay Nanotec GmbH, Germany – 1.43 2 N/A
31 Pierre Fabre SA, France 0.20 1.43 7 573.0%
32 Bracco Imaging S.p.A., Italy 0.18 1.41 3 644.9%
33 Unilever, United Kingdom (UK) 2.46 1.40 7 -46.5%
34 Evonik Industries AG, Germany 0.96 1.37 9 33.8%
35 Sodercan, S.A., Spain 0.05 1.33 10 2533.7%
36 Siemens AG, Germany 1.06 1.24 19 10.2%
37 Goodyear Innovation Center, Luxembourg – 1.24 2 N/A
38 Nestlé S.A., Switzerland 3.41 1.19 9 -67.0%
39 Earlham Institute (EI), United Kingdom (UK) 1.95 1.12 16 -45.6%
40 Veolia Environnement S.A., France 0.60 1.07 4 68.1%
41 IQE plc, United Kingdom (UK) 0.37 1.07 3 176.6%
42 Argenx SE, Belgium 0.05 1.06 2 2106.5%
43 Tofwerk AG, Switzerland 0.56 1.02 4 73.0%
44 ABB Ltd., Switzerland 0.71 1.01 4 35.7%
45 Eni s.p.a., Italy 0.91 1.00 1 3.6%
45 Science Europe AISBL, Belgium – 1.00 1 N/A
45 Javno Podjetje Vodovod-Kanalizacija d.o.o., Slovenia – 1.00 2 N/A
46 Lumileds Holding B.V., Netherlands – 0.99 4 N/A
47 National Metrology and Testing (LNE), France 1.26 0.92 9 -30.7%
48 Innate Pharma S.A., France 0.07 0.90 6 1179.7%
49 Nanoplus Nanosystems and Technologies GmbH, Germany 0.17 0.90 2 409.7%
50 AMO GmbH, Germany – 0.89 5 N/A
51 Merus N.V., Netherlands 0.43 0.88 2 94.0%
52 Bruker BioSpin GmbH, Germany 0.85 0.87 5 -4.0%
53 ELI-HU Nonprofit Ltd., Hungary 1.36 0.85 10 -41.4%
54 Servier Laboratories, France 0.44 0.83 4 78.3%
55 Saint-Gobain SA, France 1.15 0.82 5 -32.5%
56 Umicore N.V., Belgium 0.17 0.81 3 357.8%
57 DENSsolutions B.V., Netherlands 0.07 0.80 4 957.3%
58 Eau de Paris, France 0.60 0.80 2 25.9%
59 Proteros Biostructures GmbH, Germany – 0.80 3 N/A
60 SyMO-Chem B.V., Netherlands 0.57 0.79 3 30.2%
61 Genmab B.V., Netherlands 1.53 0.78 2 -51.6%
62 Arkema S.A., France 1.26 0.78 3 -41.6%
63 SpectrumGeo Ltd., United Kingdom (UK) – 0.78 2 N/A
64 Oryzon Genomics, Spain – 0.76 1 N/A
65 Equinor ASA, Norway 2.69 0.75 2 -73.6%
65 Research Center for Non Destructive Testing GmbH (RECENDT), Austria 0.64 0.75 1 10.1%
66 Ulisse BioMed SRL, Italy – 0.73 2 N/A
67 Oasen N.V., Netherlands 0.58 0.72 3 16.2%
68 Alkermes plc, Ireland – 0.71 2 N/A
69 Neem Biotech Ltd., United Kingdom (UK) – 0.71 1 N/A
70 BP plc, United Kingdom (UK) 1.52 0.71 4 -55.6%
71 Veolia Eau d'Ile de France, France – 0.70 2 N/A
72 Abzena PLC, United Kingdom (UK) 0.15 0.70 1 346.0%
73 Evides N.V., Netherlands 0.13 0.70 2 425.9%
74 EN-FIST Centre of Excellence, Slovenia 0.65 0.69 6 0.1%
74 Solvay S.A., Belgium 3.03 0.69 3 -78.3%
75 Genos Ltd., Croatia 0.46 0.67 3 38.2%
76 Infineum International Ltd., United Kingdom (UK) 0.20 0.67 2 214.6%
76 Ben-Ari Institute of Neuroarcheology, France – 0.67 1 N/A
77 BioNTech AG, Germany 1.49 0.66 6 -58.1%
78 Ivoclar Vivadent AG, Liechtenstein 0.53 0.66 4 17.5%
79 Northern Research Institute (Norut), Norway 0.34 0.66 10 82.7%
80 Nokia Corporation, Finland 2.03 0.64 8 -70.3%
81 BioMérieux SA, France – 0.63 2 N/A
82 Trumpf Laser GmbH, Germany 0.50 0.63 1 18.0%
82 Scottish Water, United Kingdom (UK) 0.60 0.63 2 -0.9%
83 NanOsc AB, Sweden – 0.62 4 N/A
84 ASML, Netherlands 0.07 0.61 3 694.7%
85 Enamine Ltd., Ukraine 0.94 0.61 2 -38.7%
86 Waternet, Netherlands 0.17 0.61 3 244.5%
87 Fimlab Laboratories Ltd., Finland 0.19 0.61 23 208.1%
88 Tagworks Pharmaceuticals, Netherlands – 0.61 2 N/A
89 allnex, Belgium – 0.60 1 N/A
90 Prozomix Limited, United Kingdom (UK) – 0.60 2 N/A
91 Immatics Biotechnologies GmbH, Germany 0.04 0.59 3 1242.1%
92 Symeres, Netherlands – 0.59 3 N/A
93 Monasterium Laboratory Skin and Hair Research Solutions GmbH, Germany – 0.59 2 N/A
94 Eurofins Scientific, Luxembourg 0.05 0.58 2 946.2%
94 Dassault Systèmes (3DS), France 0.04 0.58 2 1148.1%
95 Seaborough Research B.V., Netherlands – 0.57 1 N/A
96 Robert Bosch GmbH, Germany 0.21 0.56 10 152.9%
97 Idorsia Pharmaceuticals Ltd., Switzerland 1.00 0.56 2 -47.4%
98 Fibrostatin S.L., Spain – 0.56 1 N/A
99 Alfasigma S.p.A., Italy – 0.55 1 N/A
100 Novozymes A/S, Denmark 0.78 0.54 3 -34.9%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.